Alamar Biosciences, Inc. (ALMR) vs Nurix Therapeutics, Inc. (NRIX)
A side-by-side comparison of Alamar Biosciences, Inc. and Nurix Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALMR
Alamar Biosciences, Inc.
$34.77HealthcareDelayed quote: Oct 6, 2026, 12:10 PM EDT
NRIX
Nurix Therapeutics, Inc.
$22.83HealthcareDelayed quote: Oct 6, 2026, 12:05 PM EDT
Total return — ALMR vs NRIX
growth of $100 · dividends reinvested · last 1yALMR +73.3% (+73.3%/yr)NRIX +37.1% (+37.1%/yr)ALMR compounded faster over this window
ALMR NRIX
ALMR vs NRIX: by the numbers
- •ALMR is the larger company ($2.41B vs $2.37B market cap).
- •Both run net losses; ALMR's is the smaller (-40.18% vs -928.44% net margin).
Metrics side by side
Valuation
| Metric | ALMR | NRIX |
|---|---|---|
| P/S ratio | N/A | 64.45 |
| P/B ratio | 7.70 | 5.89 |
Profitability
| Metric | ALMR | NRIX |
|---|---|---|
| Gross margin | 56.20% | 77.55% |
| Operating margin | -42.22% | -340.16% |
| Net margin | -40.18% | -928.44% |
| ROE | N/A | -84.78% |
| ROIC | -26.95% | -77.92% |
Growth (annualized)
| Metric | ALMR | NRIX |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 9.96% |
| Total return CAGR (5Y) | N/A | -5.51% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.